Get started
NEULAND LABORATORIES LTD.NEULAND LABORATORIES LTD.NEULAND LABORATORIES LTD.

NEULAND LABORATORIES LTD.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

NEULANDLAB chart


Full chart

NEULANDLAB upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪141.81 B‬ INR
Dividend yield (indicated)
0.11%
Price to earnings Ratio (TTM)
54.50
Basic EPS (TTM)
202.75 INR
Net income (FY)
‪2.60 B‬ INR
Revenue (FY)
‪14.77 B‬ INR
Shares float
‪7.45 M‬
Beta (1Y)
0.98

About NEULAND LAB LTD.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Davuluri Sucheth Rao
Website
neulandlabs.com
Headquarters
Hyderabad
Founded
1984
ISIN
INE794A01010
FIGI
BBG000DWVWY2
Neuland Laboratories Ltd. engages in the manufacture and export of bulk pharmaceutical ingredients and intermediates for the generics industry. It also offers custom manufacturing solutions and synthetic peptides. The company was founded by Rama Mohan Rao Davuluri on January 7, 1984 and is headquartered in Hyderabad, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

NEULANDLAB news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as NEULANDLAB.

Frequently Asked Questions


The current price of NEULANDLAB is 11,174.15 INR — it has increased by 1.52% in the past 24 hours. Watch NEULAND LABORATORIES LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange NEULAND LABORATORIES LTD. stocks are traded under the ticker NEULANDLAB.
NEULANDLAB stock has fallen by −11.64% compared to the previous week, the month change is a −11.98% fall, over the last year NEULAND LABORATORIES LTD. has showed a 79.51% increase.
We've gathered analysts' opinions on NEULAND LABORATORIES LTD. future price: according to them, NEULANDLAB price has a max estimate of 16,260.00 INR and a min estimate of 14,775.00 INR. Watch NEULANDLAB chart and read a more detailed NEULAND LABORATORIES LTD. stock forecast: see what analysts think of NEULAND LABORATORIES LTD. and suggest that you do with its stocks.
NEULANDLAB reached its all-time high on Dec 4, 2024 with the price of 18,089.55 INR, and its all-time low was 59.70 INR and was reached on Jun 14, 2006. View more price dynamics on NEULANDLAB chart.
See other stocks reaching their highest and lowest prices.
NEULANDLAB stock is 2.71% volatile and has beta coefficient of 0.98. Track NEULAND LABORATORIES LTD. stock price on the chart and check out the list of the most volatile stocks — is NEULAND LABORATORIES LTD. there?
Today NEULAND LABORATORIES LTD. has the market capitalization of ‪141.81 B‬, it has increased by 4.10% over the last week.
Yes, you can track NEULAND LABORATORIES LTD. financials in yearly and quarterly reports right on TradingView.
NEULAND LABORATORIES LTD. is going to release the next earnings report on Jul 31, 2025. Keep track of upcoming events with our Earnings Calendar.
NEULANDLAB earnings for the last quarter are 21.64 INR per share, whereas the estimation was 44.26 INR resulting in a −51.12% surprise. The estimated earnings for the next quarter are 56.85 INR per share. See more details about NEULAND LABORATORIES LTD. earnings.
NEULAND LABORATORIES LTD. revenue for the last quarter amounts to ‪3.14 B‬ INR, despite the estimated figure of ‪4.03 B‬ INR. In the next quarter, revenue is expected to reach ‪4.20 B‬ INR.
NEULANDLAB net income for the last quarter is ‪278.06 M‬ INR, while the quarter before that showed ‪1.02 B‬ INR of net income which accounts for −72.63% change. Track more NEULAND LABORATORIES LTD. financial stats to get the full picture.
Yes, NEULANDLAB dividends are paid annually. The last dividend per share was 14.00 INR. As of today, Dividend Yield (TTM)% is 0.13%. Tracking NEULAND LABORATORIES LTD. dividends might help you take more informed decisions.
NEULAND LABORATORIES LTD. dividend yield was 0.10% in 2024, and payout ratio reached 5.92%. The year before the numbers were 0.22% and 5.99% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NEULAND LABORATORIES LTD. EBITDA is ‪3.23 B‬ INR, and current EBITDA margin is 21.89%. See more stats in NEULAND LABORATORIES LTD. financial statements.
Like other stocks, NEULANDLAB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NEULAND LABORATORIES LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NEULAND LABORATORIES LTD. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NEULAND LABORATORIES LTD. stock shows the buy signal. See more of NEULAND LABORATORIES LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.